Cerebrospinal fluid amyloid and neurodegeneration biomarkers in the diagnosis and prognosis of amyotrophic lateral sclerosis: a multicohort observational study

Kazuki Obara, Shorena Janelidze, Daisuke Ito, Linda Karlsson, Munetaka Yamamoto, Andrea Mastrangelo, Sinh Tran, Koyo Tsujikawa, Yosuke Nishio, Tomoo Ogi, Veria Vacchiano, Rocco Liguori, Ryoichi Nakamura, Naoki Atsuta, Gen Sobue, Christer Nilsson, Piero Parchi, Masahisa Katsuno, Niklas Mattsson-Carlgren

Open source

DOI: 10.1016/j.ebiom.2026.106511
Published: 2026-10
Container: eBioMedicine
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ebiom.2026.106511,
  title = {Cerebrospinal fluid amyloid and neurodegeneration biomarkers in the diagnosis and prognosis of amyotrophic lateral sclerosis: a multicohort observational study},
  author = {Kazuki Obara and Shorena Janelidze and Daisuke Ito and Linda Karlsson and Munetaka Yamamoto and Andrea Mastrangelo and Sinh Tran and Koyo Tsujikawa and Yosuke Nishio and Tomoo Ogi and Veria Vacchiano and Rocco Liguori and Ryoichi Nakamura and Naoki Atsuta and Gen Sobue and Christer Nilsson and Piero Parchi and Masahisa Katsuno and Niklas Mattsson-Carlgren},
  year = {2026},
  journal = {eBioMedicine},
  doi = {10.1016/j.ebiom.2026.106511},
  url = {https://doi.org/10.1016/j.ebiom.2026.106511}
}

RIS

TY  - JOUR
TI  - Cerebrospinal fluid amyloid and neurodegeneration biomarkers in the diagnosis and prognosis of amyotrophic lateral sclerosis: a multicohort observational study
AU  - Kazuki Obara
AU  - Shorena Janelidze
AU  - Daisuke Ito
AU  - Linda Karlsson
AU  - Munetaka Yamamoto
AU  - Andrea Mastrangelo
AU  - Sinh Tran
AU  - Koyo Tsujikawa
AU  - Yosuke Nishio
AU  - Tomoo Ogi
AU  - Veria Vacchiano
AU  - Rocco Liguori
AU  - Ryoichi Nakamura
AU  - Naoki Atsuta
AU  - Gen Sobue
AU  - Christer Nilsson
AU  - Piero Parchi
AU  - Masahisa Katsuno
AU  - Niklas Mattsson-Carlgren
PY  - 2026
JO  - eBioMedicine
DO  - 10.1016/j.ebiom.2026.106511
UR  - https://doi.org/10.1016/j.ebiom.2026.106511
ER  -

APA

Obara, K., Janelidze, S., Ito, D., Karlsson, L., Yamamoto, M., Mastrangelo, A., Tran, S., Tsujikawa, K., Nishio, Y., Ogi, T., Vacchiano, V., Liguori, R., Nakamura, R., Atsuta, N., Sobue, G., Nilsson, C., Parchi, P., Katsuno, M., & Mattsson-Carlgren, N. (2026). Cerebrospinal fluid amyloid and neurodegeneration biomarkers in the diagnosis and prognosis of amyotrophic lateral sclerosis: a multicohort observational study. eBioMedicine. https://doi.org/10.1016/j.ebiom.2026.106511

Source records

crossref · retrieved 2026-11-10T20:53:47.536Z